CUBIST PHARMACEUTICALS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011	FY2010 12 months to Dec 31, 2010
Revenues:
U.S. product revenues, net
International product revenues
Service revenues
Other revenues
Total revenues, net
Costs and expenses:
Cost of product revenues
Research and development
Impairment of in-process research and development
Impairment charges
Contingent consideration
Selling, general and administrative
Restructuring charges
Total costs and expenses
Sales and marketing
General and administrative

Operating income
Other income (expense), net:
Interest income
Interest expense
Other income (expense)
Total other income (expense), net
(Loss) income before income taxes
(Benefit) provision for income taxes
Net income
Net (loss) income
Basic net (loss) income per common share (in dollars per share)
Diluted net (loss) income per common share (in dollars per share)
Shares used in calculating:
Basic net (loss) income per common share (in shares)
Diluted net (loss) income per common share (in shares)

Comments